vaccine trials

As COVID-19 vaccine trials begin for children, many parents may be understandably wary about signing their own child up as a subject. So we got Peter Pitts, a former FDA associate commissioner and president of the Center for Medicine in the Public Interest, to break down how vaccine trials for children work and how researchers ensure they’re safe.

Dances and duets are not the only videos trending on TikTok. NBC News youth and internet culture reporter Kalhan Rosenblatt discusses how young people are turning to the video app for information about the COVID-19 vaccines, and gives us a firsthand look at a TikToker’s experience as a vaccine trial participant.

Moderna and Pfizer have now both reported that their COVID-19 vaccines have been highly effective in trials. But how do they work, and what are the differences between the two? Benjamin Neuman, a professor of biological studies at Texas A&M, breaks down the specifics of both vaccines.

Moderna announced Monday that preliminary data from its phase 3 trial showed its coronavirus vaccine is more than 94% effective in preventing COVID-19. Dr. Bob Lahita, a clinical professor at New York Medical College and the Chairman of the Department of Medicine at St. Joseph’s Healthcare System, breaks down the “very exciting news,” and why March and April could be...

Pfizer has released early data that shows its COVID-19 vaccine is more than 90% effective. Former FDA Associate Commissioner Peter Pitts says this effectiveness rate represents a “game changer” but cautions there is still a long road ahead before a vaccine is ready for the general public.

Sue O’Connell sat down with Kenneth Mayer, MD, Medical Research Director and Co-Chair of the Fenway Institute, who talks about how his group has been activated to help facilitate trials for COVID-19 vaccine candidates and antibodies.

Dr. Chris Pernell, a New Jersey public health physician, became a patient in Moderna’s COVID-19 vaccine trial after she lost her father to the virus. She joins LX News to discuss why it was important for her to join the trial to honor her father and to advocate for better health care for Black and brown communities that have suffered...

A California woman volunteering for Moderna’s COVID-19 vaccine trial said she wasn’t afraid to offer herself up as a test subject, and never had second thoughts even after the side effects kicked in. Debbie Honeycutt, 69, said she started feeling mild, flu-like symptoms after her second dose of the vaccine. The Scripps Ranch resident got her first dose of...

Just weeks after announcing COVID-19 vaccines were in the final stages, Johnson & Johnson has announced it is pausing its clinical trials.

A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.

Writer Molly Jong-Fast walks us through her experience of participating in a COVID-19 vaccine trial, why she did it, and why you are much safer taking the vaccine than taking your chances of contracting the virus.

The president of Xavier University of Louisiana, Reynold Verret, is participating in a Covid-19 vaccine trial and encouraging Black students to follow suit. He explains why it is so important for people of color to be represented in the vaccine trials given that they are disproportionately dying from the virus.